Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.088 EUR | +0.20% | -3.86% | +154.14% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 670M 620M |
---|---|---|---|---|---|
Net income 2024 * | -91M -84.25M | Net income 2025 * | -104M -96.28M | EV / Sales 2024 * | - |
Net cash position 2024 * | 184M 171M | Net cash position 2025 * | 99.5M 92.12M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.12
x | P/E ratio 2025 * |
-6.64
x | Employees | 57 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on Mind Medicine (MindMed)
1 day | +0.42% | ||
1 week | -3.86% | ||
Current month | +57.94% | ||
1 month | +81.74% | ||
3 months | +155.95% | ||
6 months | +160.61% | ||
Current year | +154.14% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Barrow
CEO | Chief Executive Officer | - | 21-01-13 |
Schond Greenway
DFI | Director of Finance/CFO | 52 | 22-05-22 |
Miri Wernli
PSD | President | 71 | 20-02-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andreas Krebs
BRD | Director/Board Member | 66 | 21-09-28 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 22-08-10 |
David Gryska
BRD | Director/Board Member | 68 | 23-06-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 8.6 | -5.18% | 206 |
24-03-27 | 9.07 | +0.78% | 1,950 |
24-03-26 | 9 | -7.26% | 680 |
24-03-25 | 9.705 | -1.67% | 1,452 |
24-03-22 | 9.87 | +10.34% | 604 |
Delayed Quote Deutsche Boerse AG, March 28, 2024 at 09:40 am EDT
More quotesEPS Revisions
- Stock
- Equities
- Stock Mind Medicine (MindMed)
- Stock Mind Medicine (MindMed) - Deutsche Boerse AG